By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kereos, Inc. 

St. Louis  Missouri    U.S.A.
Phone: N/A Fax:



Company News
Kereos, Inc. And Washington University School of Medicine Release: Academia And Industry Join Forces To Bring The Future Of Medicine To The Public 10/18/2006 11:20:07 AM
Published Data Show Kereos, Inc. Technology Specifically Targets Arterial Plaque 9/29/2006 10:43:58 AM
Kereos, Inc. Appoints Allen Nickols, Ph.D., As Vice President Of Biology 12/13/2005 11:17:00 AM
Kereos, Inc.' Collaborators Present On Targeted Therapies For Cardiovascular Disease 11/15/2005 10:55:39 AM
Kereos, Inc. Increases Series B Financing Total To $20 Million10/19/2005 5:13:23 PM
Kereos, Inc. And Washington University in St. Louis To Develop Therapeutics For Unstable Plaque Under New $7.3 Million Grant 10/19/2005 5:12:14 PM
Kereos, Inc. And Dow Chemical Company (DOW) Sign Licensing Agreement For Novel Targeted Imaging Agents10/19/2005 5:11:36 PM
Kereos, Inc. Awarded Missouri Governor's Technology Award For New Approach To Combating Serious Diseases10/19/2005 5:11:28 PM
Kereos, Inc. Appoints Michael Loberg, NitroMed, Inc. (NTMD) President And CEO, To Board Of Directors10/19/2005 5:11:09 PM
Kereos, Inc. To Present At Windhover Information Inc.'s "The Start-Up Forum 2005"10/19/2005 5:10:23 PM